Table 2.
Summary of society guideline recommendations on PSS prophylaxis.
| Guidelines | Primary prophylaxis | Secondary prophylaxis | |
|---|---|---|---|
| European Stroke Organisation (36) | Weak recommendation against primary prophylaxis | EPSS: only a weak recommendation can be made in favour of secondary prophylaxis, and we suggest not generally employing secondary ASM prophylaxis. LPSS: employing secondary ASM prophylaxis after one unprovoked seizure needs to be considered. |
|
| American Heart Association/ American Stroke Association | Ischaemic stroke (136) | Not recommended | Recurrent seizures should be treated in a manner similar to when they occur with acute neurological conditions; ASMs should be selected based on patient characteristics |
| Spontaneous intracerebral haemorrhage (125) | Should not be treated prophylactically with ASMs | Recommended to improve functional outcomes and prevent brain injury from prolonged seizures | |
| Aneurysmal SAH (126) | Benefit of routine administration after aneurysmal SAH not supported by evidence; prophylactic ASM use may be reasonable to prevent seizures in patients with aneurysmal SAH if accompanied by high seizure-risk features | Both EPSS and LPSS warrant longer-term antiseizure medication that should be managed in the postoperative period by a clinician who specialises in seizure management. | |